| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2014/02/15 | 05 : 15 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 2013/10/11 | 04 : 54 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 2013/09/23 | 22 : 35 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 2013/09/17 | 19 : 00 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 2013/09/17 | 19 : 00 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 2013/09/14 | 07 : 25 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 2013/09/14 | 07 : 24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 2013/09/14 | 07 : 23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 2013/09/14 | 07 : 22 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 2013/09/14 | 07 : 20 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 2013/09/14 | 07 : 20 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 2013/09/14 | 05 : 03 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 2013/09/14 | 05 : 03 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 2013/09/14 | 05 : 02 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 2013/09/14 | 05 : 02 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 2013/09/14 | 05 : 02 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 2013/09/14 | 05 : 02 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 2013/09/14 | 05 : 02 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 2013/09/14 | 05 : 01 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 2013/09/12 | 06 : 11 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 2013/09/12 | 06 : 10 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 2013/09/12 | 06 : 08 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 2013/09/12 | 05 : 30 | Business Wire | Cubist Pharmaceuticals Completes Acquisition of Trius Therapeutics | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 2013/09/12 | 05 : 30 | Business Wire | Cubist Pharmaceuticals Completes Acquisition of Trius Therapeutics | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 2013/09/12 | 05 : 26 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 2013/09/12 | 00 : 00 | Business Wire | Cubist Pharmaceuticals Announces Results of Tender Offer for Outstanding Shares of Trius Therapeutics | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 2013/09/12 | 00 : 00 | Business Wire | Cubist Pharmaceuticals Announces Results of Tender Offer for Outstanding Shares of Trius Therapeutics | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 2013/09/07 | 05 : 01 | GlobeNewswire Inc. | Trius Therapeutics to Present Data From Antibiotics Development Programs at ICAAC 2013 | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 2013/09/06 | 05 : 51 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 2013/09/06 | 05 : 46 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |